Affiliation
Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, UK.Issue Date
2020
Metadata
Show full item recordCitation
James EC, McNeish IA, Cook AD, Kaplan R, Clamp AR. Progression-free survival in the ICON8 trial Authors' reply. Lancet. 2020;396(10253):757.Journal
LancetDOI
10.1016/s0140-6736(20)31177-6PubMed ID
32919511Additional Links
https://dx.doi.org/10.1016/s0140-6736(20)31177-6Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/s0140-6736(20)31177-6
Scopus Count
Collections
Related articles
- Progression-free survival in the ICON8 trial.
- Authors: Ludmir EB, McCaw ZR, Fuller CD, Wei LJ
- Issue date: 2020 Sep 12
- Progression-free survival in the ICON8 trial.
- Authors: Balieiro Anastacio da Costa AA, Baiocchi G, Guimarães APG
- Issue date: 2020 Sep 12
- Authors' Reply to Schoenfeld: "Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors".
- Authors: Michiels S, Saad ED, Buyse M
- Issue date: 2017 Jul
- Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review.
- Authors: Weng JC, Li D, Wang L, Wu Z, Wang JM, Li GL, Jia W, Zhang LW, Zhang JT
- Issue date: 2018 Oct 12
- Joint modeling of progression-free and overall survival and computation of correlation measures.
- Authors: Meller M, Beyersmann J, Rufibach K
- Issue date: 2019 Sep 30